EdgarLookup

Serina Therapeutics, Inc. — All Filings

475 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-12B 10-12B/A 10-K 10-K/A 10-Q 144 3 3/A 4 424B3 424B5 425 5 8-K ARS CERT CORRESP CT ORDER D DEF 14A DEFA14A DEFC14A DEFR14A EFFECT POS EX PRE 14A PRER14A S-1 S-1/A S-3 S-3/A S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SEC STAFF ACTION UPLOAD
Form Description Accession Number Filed Period
SC 13G 0000919574-18-007920 Dec 10, 2018
8-K AGEX THERAPEUTICS, INC. 8-K 0001157523-18-002491 Nov 29, 2018
CT ORDER 9999999997-18-009139 Nov 28, 2018
3 FORM 3 SUBMISSION 0001209191-18-060153 Nov 28, 2018 Nov 27, 2018
3 PRIMARY DOCUMENT 0000908662-18-000232 Nov 27, 2018
3 PRIMARY DOCUMENT 0000908662-18-000231 Nov 27, 2018
SEC STAFF ACTION 9999999997-18-009135 Nov 27, 2018
CERT NYSE CERTIFICATION AGEX THERAPEUTICS, INC. 0001143313-18-000071 Nov 27, 2018
3 PRIMARY DOCUMENT 0000908662-18-000233 Nov 27, 2018
3 FORM 3 SUBMISSION 0001209191-18-060088 Nov 27, 2018
3 FORM 3 SUBMISSION 0001209191-18-060087 Nov 27, 2018
3 FORM 3 SUBMISSION 0001209191-18-060085 Nov 27, 2018
3 FORM 3 SUBMISSION 0001209191-18-060084 Nov 27, 2018
3 FORM 3 SUBMISSION 0001209191-18-060083 Nov 27, 2018
3 FORM 3 SUBMISSION 0001209191-18-060082 Nov 27, 2018
10-12B/A 0001493152-18-016705 Nov 26, 2018
10-12B/A 0001493152-18-015167 Nov 5, 2018
10-12B/A 0001493152-18-014695 Oct 22, 2018
10-12B/A 0001493152-18-012759 Aug 30, 2018
D 0001462573-18-000003 Aug 27, 2018
10-12B/A 0001493152-18-010218 Jul 19, 2018
D 0001462573-18-000002 Jun 21, 2018
10-12B 0001493152-18-008376 Jun 8, 2018
D 0001462573-18-000001 Jan 31, 2018
D 0001462573-17-000001 Jul 10, 2017